New five-day rules are recommended, with variation depending upon vaccination status.

Molnupiravir, Paxlovid, and AZD7442 have shown promise in Phase 3 trials.

Those previously infected by the virus may face long-term health complications.

Rulings from U.S. District Courts have impeded vaccine requirements among certain workers.

All adults may now receive a booster shot of any COVID-19 vaccine.

Strategies for a safer, healthier workforce amid COVID-19 and beyond.

All COVID-19 vaccines now have emergency use authorization for a booster dose.

Transparency and trust help keep employees informed and engaged amid disruption.

A new migraine medication, various generics, and more.

Long-term health impacts of COVID-19 can complicate claims